Back
NeuroOne Medical Technologies Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer16.jpg)
Buffet, Bloomberg & 48 Congress Members Are Buying 1 Sector
Click here for the details.
Sell
23
NMTC
NeuroOne Medical Technologies
Last Price:
0.80
Seasonality Move:
3.19%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer13.jpg)
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.NeuroOne Medical Technologies Price Quote
$0.80
-0.01 (-0.68%)
(Updated: July 1, 2024 at 9:40 AM ET)
NeuroOne Medical Technologies Key Stats
Sell
23
NeuroOne Medical Technologies (NMTC)
is a Sell
Day range:
$0.74 - $0.81
52-week range:
$0.65 - $2.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.85
P/B ratio:
5.75%
Volume:
64.4K
Avg. volume:
174.5K
1-year change:
-26.1%
Market cap:
$22.2M
Revenue:
$2M
EPS:
$-0.58
How Much Does NeuroOne Medical Technologies Make?
-
How Much Are NeuroOne Medical Technologies's Sales Annually?
NMTC Revenues are $2M -
How Much Profit Does NeuroOne Medical Technologies's Make A Year?
NMTC net income is -$11.9M
Is NeuroOne Medical Technologies Growing As A Company?
-
What Is NeuroOne Medical Technologies's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.95% -
What Is NeuroOne Medical Technologies's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
NeuroOne Medical Technologies Stock Price Performance
-
Did NeuroOne Medical Technologies Stock Go Up Last Month?
NeuroOne Medical Technologies share price went down by -18.22% last month -
Did NMTC's Share Price Rise Over The Last Year?
NMTC share price fell by -26.1% over the past 1 year
What Is NeuroOne Medical Technologies 52-Week High & Low?
-
What Is NeuroOne Medical Technologies’s 52-Week High Share Price?
NeuroOne Medical Technologies has traded as high as $2.00 over the past 52 weeks -
What Is NeuroOne Medical Technologies’s 52-Week Low Share Price?
NeuroOne Medical Technologies has traded as low as $0.65 over the past 52 weeks
NeuroOne Medical Technologies Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy NeuroOne Medical Technologies?
-
How Much Debt Does NeuroOne Medical Technologies Have?
Total long term debt quarterly is $0 -
How Much Cash Does NeuroOne Medical Technologies Have?
Cash and short term investments quarterly total is $2.4M -
What Is NeuroOne Medical Technologies’s Book Value Per Share?
Book value per share is 0.15
Is NeuroOne Medical Technologies Cash Flow Positive?
-
What Is NMTC Cash Flow From Operations?
Cash flow from operations (TTM) is -$11.8M -
What Is NeuroOne Medical Technologies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $9.9M -
What Is NeuroOne Medical Technologies’s Cash Flow From Investing?
Cash flow from investing (TTM) is $742.1K
NeuroOne Medical Technologies Return On Invested Capital
-
Is Management Doing A Good Job?
NMTC return on invested capital is -267.01% -
What Is NeuroOne Medical Technologies Return On Assets?
ROA measures how assets are converting to revenues and is -198.34% -
What Is NMTC Return On Equity?
ROE is a measure of profitability and is -267.01%
NeuroOne Medical Technologies Earnings Date & Stock Price
-
What Is NeuroOne Medical Technologies's Stock Price Today?
A single share of NMTC can be purchased today for 0.81 -
What Is NeuroOne Medical Technologies’s Stock Symbol?
NeuroOne Medical Technologies trades on the nasdaq under the ticker symbol: NMTC -
When Is NeuroOne Medical Technologies’s Next Earnings Date?
The next quarterly earnings date for NeuroOne Medical Technologies is scheduled on August 30, 2024 -
When Is NMTC's next ex-dividend date?
NeuroOne Medical Technologies's next ex-dividend date is May 20, 2020 -
How To Buy NeuroOne Medical Technologies Stock?
You can buy NeuroOne Medical Technologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
NeuroOne Medical Technologies Competitors
-
Who Are NeuroOne Medical Technologies's Competitors?
Below is a list of companies who compete with NeuroOne Medical Technologies or are related in some way:
NeuroOne Medical Technologies Dividend Yield
Data Unavailable
NeuroOne Medical Technologies Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 195.45% | 14.75% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 2.00 |
Upside from Last Price: | 148.29% |